AMRN
Price
$12.74
Change
+$0.79 (+6.61%)
Updated
Oct 28 closing price
Capitalization
269.21M
Intraday BUY SELL Signals
NAGE
Price
$2.54
Change
+$0.04 (+1.60%)
Updated
Oct 28 closing price
Capitalization
200.98M
6 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMRN vs NAGE

AMRN vs NAGE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AMRN vs. NAGE commentary
Oct 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and NAGE is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AMRN with price predictions
Oct 28, 2026

AMRN's RSI Indicator ascends from oversold territory

The RSI Oscillator for AMRN moved out of oversold territory on October 22, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In 27 of the 35 cases the stock moved higher. This puts the odds of a move higher at 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on AMRN as a result. In 61 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for AMRN just turned positive on October 22, 2026. Looking at past instances where AMRN's MACD turned positive, the stock continued to rise in 42 of 55 cases over the following month. The odds of a continued upward trend are 76%.

Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMRN advanced for three days, in 184 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMRN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

AMRN broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AMRN entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.607) is normal, around the industry mean (-2.729). P/E Ratio (-10.621) is within average values for comparable stocks, (20.997). Projected Growth (PEG Ratio) (3.220) is also within normal values, averaging (5.738). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (1.554) is also within normal values, averaging (4.033).

The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. AMRN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock worse than average.

A.I.Advisor
a Summary for NAGE with price predictions
Oct 28, 2026

NAGE's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for NAGE turned positive on October 27, 2026. Looking at past instances where NAGE's MACD turned positive, the stock continued to rise in 41 of 50 cases over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NAGE's RSI Indicator exited the oversold zone, 27 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 73 cases where NAGE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on NAGE as a result. In 72 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

Following a +4.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where NAGE advanced for three days, in 188 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

NAGE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAGE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for NAGE entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.435) is normal, around the industry mean (1.736). P/E Ratio (12.700) is within average values for comparable stocks, (6.461). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.056) among similar stocks. P/S Ratio (1.976) is also within normal values, averaging (4.925).

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. NAGE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NAGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
AMRN vs NAGE: Fundamental Ratings
AMRN
NAGE
OUTLOOK RATING
1..100
1115
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9245
PRICE GROWTH RATING
1..100
7585
P/E GROWTH RATING
1..100
3293
SEASONALITY SCORE
1..100
509

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAGE's Valuation (62) in the Chemicals Specialty industry is in the same range as AMRN (66) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew similarly to AMRN’s over the last 12 months.

NAGE's Profit vs Risk Rating (100) in the Chemicals Specialty industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew similarly to AMRN’s over the last 12 months.

NAGE's SMR Rating (45) in the Chemicals Specialty industry is somewhat better than the same rating for AMRN (92) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew somewhat faster than AMRN’s over the last 12 months.

AMRN's Price Growth Rating (75) in the Pharmaceuticals Other industry is in the same range as NAGE (85) in the Chemicals Specialty industry. This means that AMRN’s stock grew similarly to NAGE’s over the last 12 months.

AMRN's P/E Growth Rating (32) in the Pharmaceuticals Other industry is somewhat better than the same rating for NAGE (93) in the Chemicals Specialty industry. This means that AMRN’s stock grew somewhat faster than NAGE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNNAGE
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 15 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
81%
COMPARISON
Comparison
Oct 29, 2026
Stock price -- (AMRN: $12.74 vs. NAGE: $2.54)
Brand notoriety: AMRN: Notable vs. NAGE: Not notable
AMRN represents the Pharmaceuticals: Major, while NAGE is part of the Food: Major Diversified industry
Current volume relative to the 65-day Moving Average: AMRN: 223% vs. NAGE: 64%
Market capitalization -- AMRN: $269.21M vs. NAGE: $200.98M
AMRN [@Pharmaceuticals: Major] is valued at $269.21M. NAGE’s [@Food: Major Diversified] market capitalization is $200.98M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $4.8K to $1.14T. The market cap for tickers in the [@Food: Major Diversified] industry ranges from $68.81K to $239.66B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $207.87B. The average market capitalization across the [@Food: Major Diversified] industry is $3.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 1 FA rating(s) are green while NAGE’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 1 green, 4 red.
  • NAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMRN and NAGE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 4 TA indicator(s) are bullish while NAGE’s TA Score has 6 bullish TA indicator(s).

  • AMRN’s TA Score: 4 bullish, 4 bearish.
  • NAGE’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, NAGE is a better buy in the short-term than AMRN.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а +10.73% price change this week, while NAGE (@Food: Major Diversified) price change was +2.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.41%. For the same industry, the average monthly price growth was -5.87%, and the average quarterly price growth was +2.51%.

The average weekly price growth across all stocks in the @Food: Major Diversified industry was -1.58%. For the same industry, the average monthly price growth was -7.75%, and the average quarterly price growth was -21.11%.

Reported Earning Dates

NAGE is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-0.41% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Food: Major Diversified (-1.58% weekly)

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

View a ticker or compare two or three
AMRN
Daily Signal:
Gain/Loss:
NAGE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with CNTB. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then CNTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+6.65%
CNTB - AMRN
55%
Loosely correlated
+0.33%
HRTX - AMRN
44%
Loosely correlated
+2.45%
MGNX - AMRN
44%
Loosely correlated
+1.23%
ALXO - AMRN
43%
Loosely correlated
+7.27%
ARWR - AMRN
40%
Loosely correlated
+2.00%
More

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
+1.60%
AXON - NAGE
43%
Loosely correlated
-0.63%
USNA - NAGE
39%
Loosely correlated
+3.91%
TRDA - NAGE
38%
Loosely correlated
+9.75%
AMRN - NAGE
35%
Loosely correlated
+6.65%
CYTK - NAGE
35%
Loosely correlated
-0.39%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LOUP81.851.28
+1.59%
Innovator Deepwater Frontier Tech ETF (LOUP)
ONEQ104.680.33
+0.32%
Fidelity Nasdaq Composite Index ETF (ONEQ)
IFEB31.360.07
+0.22%
Innovator International Developed Power Buffer ETF February (IFEB)
EBI65.35N/A
N/A
The RBB Fund Trust Longview Advantage ETF
BNDD97.86-0.42
-0.43%
Quadratic Deflation ETF (BNDD)